

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lymphangiogenesis (GO:0001946) | 6.09770326 |
| 2 | lymph vessel development (GO:0001945) | 5.94349333 |
| 3 | vascular endothelial growth factor signaling pathway (GO:0038084) | 5.94319049 |
| 4 | surfactant homeostasis (GO:0043129) | 5.83730661 |
| 5 | blood vessel maturation (GO:0001955) | 5.57095130 |
| 6 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.82893370 |
| 7 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 4.79607692 |
| 8 | regulation of endothelial cell differentiation (GO:0045601) | 4.67345828 |
| 9 | morphogenesis of an endothelium (GO:0003159) | 4.57313113 |
| 10 | endothelial tube morphogenesis (GO:0061154) | 4.57313113 |
| 11 | chemical homeostasis within a tissue (GO:0048875) | 4.51858847 |
| 12 | basement membrane organization (GO:0071711) | 4.35340346 |
| 13 | response to peptidoglycan (GO:0032494) | 4.33644019 |
| 14 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 4.29046313 |
| 15 | axon extension involved in axon guidance (GO:0048846) | 4.29046313 |
| 16 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.23155302 |
| 17 | renal filtration (GO:0097205) | 4.20451651 |
| 18 | positive regulation of vasculogenesis (GO:2001214) | 4.20169320 |
| 19 | regulation of vasculogenesis (GO:2001212) | 4.18122502 |
| 20 | glomerular filtration (GO:0003094) | 4.07771563 |
| 21 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.02257145 |
| 22 | negative regulation of interleukin-12 production (GO:0032695) | 3.88035194 |
| 23 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.87759802 |
| 24 | cell adhesion mediated by integrin (GO:0033627) | 3.81766727 |
| 25 | wound healing, spreading of epidermal cells (GO:0035313) | 3.67680136 |
| 26 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.63131217 |
| 27 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.60244463 |
| 28 | apoptotic cell clearance (GO:0043277) | 3.57804458 |
| 29 | protein heterotrimerization (GO:0070208) | 3.57617916 |
| 30 | endothelial cell morphogenesis (GO:0001886) | 3.57576723 |
| 31 | blood vessel endothelial cell migration (GO:0043534) | 3.55737845 |
| 32 | regulation of mononuclear cell migration (GO:0071675) | 3.51355041 |
| 33 | macrophage activation involved in immune response (GO:0002281) | 3.49987338 |
| 34 | blood vessel remodeling (GO:0001974) | 3.49682760 |
| 35 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.49239622 |
| 36 | neutrophil activation involved in immune response (GO:0002283) | 3.47336612 |
| 37 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.44273785 |
| 38 | artery development (GO:0060840) | 3.42163767 |
| 39 | lung lobe morphogenesis (GO:0060463) | 3.39736358 |
| 40 | endothelial cell differentiation (GO:0045446) | 3.38750751 |
| 41 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.35328472 |
| 42 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.35244580 |
| 43 | germinal center formation (GO:0002467) | 3.30428028 |
| 44 | low-density lipoprotein particle clearance (GO:0034383) | 3.28192316 |
| 45 | glomerular basement membrane development (GO:0032836) | 3.21325710 |
| 46 | endothelium development (GO:0003158) | 3.17891580 |
| 47 | detection of molecule of bacterial origin (GO:0032490) | 3.17533020 |
| 48 | T-helper 1 type immune response (GO:0042088) | 3.13016345 |
| 49 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.12590949 |
| 50 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.12283679 |
| 51 | collagen fibril organization (GO:0030199) | 3.10914264 |
| 52 | lung vasculature development (GO:0060426) | 3.09621984 |
| 53 | sprouting angiogenesis (GO:0002040) | 3.09121334 |
| 54 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.08248161 |
| 55 | glycosphingolipid catabolic process (GO:0046479) | 3.07695825 |
| 56 | patterning of blood vessels (GO:0001569) | 3.05430192 |
| 57 | response to thyroid hormone (GO:0097066) | 3.04515186 |
| 58 | positive regulation of p38MAPK cascade (GO:1900745) | 3.03192792 |
| 59 | stress fiber assembly (GO:0043149) | 3.02867616 |
| 60 | cellular response to arsenic-containing substance (GO:0071243) | 3.02334460 |
| 61 | substrate-dependent cell migration (GO:0006929) | 3.02123949 |
| 62 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.00749640 |
| 63 | mesodermal cell differentiation (GO:0048333) | 3.00291700 |
| 64 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.98307256 |
| 65 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.98307256 |
| 66 | modulation by symbiont of host immune response (GO:0052553) | 2.98307256 |
| 67 | positive regulation by symbiont of host defense response (GO:0052509) | 2.98307256 |
| 68 | modulation by symbiont of host defense response (GO:0052031) | 2.98307256 |
| 69 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.98307256 |
| 70 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.95307894 |
| 71 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.93076930 |
| 72 | endothelial cell proliferation (GO:0001935) | 2.93019029 |
| 73 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.92929915 |
| 74 | chondrocyte proliferation (GO:0035988) | 2.92194702 |
| 75 | regulation of macrophage chemotaxis (GO:0010758) | 2.91551773 |
| 76 | venous blood vessel morphogenesis (GO:0048845) | 2.90821323 |
| 77 | cellular extravasation (GO:0045123) | 2.89157760 |
| 78 | vasculogenesis (GO:0001570) | 2.89154715 |
| 79 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.88917258 |
| 80 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.88592634 |
| 81 | macrophage activation (GO:0042116) | 2.85147725 |
| 82 | detection of other organism (GO:0098543) | 2.84817696 |
| 83 | oligosaccharide catabolic process (GO:0009313) | 2.83123719 |
| 84 | endodermal cell differentiation (GO:0035987) | 2.81805384 |
| 85 | regulation of p38MAPK cascade (GO:1900744) | 2.81614191 |
| 86 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.80448023 |
| 87 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.78371515 |
| 88 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.77521800 |
| 89 | adhesion of symbiont to host (GO:0044406) | 2.76450498 |
| 90 | response to muramyl dipeptide (GO:0032495) | 2.76136442 |
| 91 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.75455233 |
| 92 | barbed-end actin filament capping (GO:0051016) | 2.75416692 |
| 93 | pinocytosis (GO:0006907) | 2.74185594 |
| 94 | monocyte chemotaxis (GO:0002548) | 2.74002786 |
| 95 | collagen metabolic process (GO:0032963) | 2.73684122 |
| 96 | response to progesterone (GO:0032570) | 2.73304141 |
| 97 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.72656679 |
| 98 | detection of external biotic stimulus (GO:0098581) | 2.72590814 |
| 99 | endothelial cell chemotaxis (GO:0035767) | 2.72014183 |
| 100 | glycolipid catabolic process (GO:0019377) | 2.71708567 |
| 101 | positive regulation of macrophage cytokine production (GO:0060907) | 2.70620227 |
| 102 | response to laminar fluid shear stress (GO:0034616) | 2.70005922 |
| 103 | establishment of endothelial barrier (GO:0061028) | 2.69877591 |
| 104 | regulation of podosome assembly (GO:0071801) | 2.69639434 |
| 105 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.69607357 |
| 106 | regulation of tight junction assembly (GO:2000810) | 2.69495503 |
| 107 | decidualization (GO:0046697) | 2.69041839 |
| 108 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.68140111 |
| 109 | skin morphogenesis (GO:0043589) | 2.67415995 |
| 110 | ovulation from ovarian follicle (GO:0001542) | 2.67193889 |
| 111 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.66556999 |
| 112 | growth hormone receptor signaling pathway (GO:0060396) | 2.65311083 |
| 113 | endothelial cell migration (GO:0043542) | 2.63265497 |
| 114 | wound healing, spreading of cells (GO:0044319) | 2.63176554 |
| 115 | mRNA transcription (GO:0009299) | 2.62899677 |
| 116 | endocardial cushion development (GO:0003197) | 2.62874635 |
| 117 | protein localization to endosome (GO:0036010) | 2.62736314 |
| 118 | hemidesmosome assembly (GO:0031581) | 2.62732373 |
| 119 | regulation of mast cell degranulation (GO:0043304) | 2.61730633 |
| 120 | epithelial cell-cell adhesion (GO:0090136) | 2.61727849 |
| 121 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.60281669 |
| 122 | collagen catabolic process (GO:0030574) | 2.60016976 |
| 123 | adhesion of symbiont to host cell (GO:0044650) | 2.59462094 |
| 124 | virion attachment to host cell (GO:0019062) | 2.59462094 |
| 125 | multicellular organismal metabolic process (GO:0044236) | 2.59374897 |
| 126 | positive regulation of leukocyte degranulation (GO:0043302) | 2.59216556 |
| 127 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.57743678 |
| 128 | keratan sulfate catabolic process (GO:0042340) | 2.57602402 |
| 129 | heart trabecula formation (GO:0060347) | 2.57580035 |
| 130 | vasculature development (GO:0001944) | 2.56276405 |
| 131 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.54314932 |
| 132 | cell-substrate junction assembly (GO:0007044) | 2.53688905 |
| 133 | angiogenesis involved in wound healing (GO:0060055) | 2.53644655 |
| 134 | negative regulation of endothelial cell migration (GO:0010596) | 2.53147670 |
| 135 | multicellular organismal catabolic process (GO:0044243) | 2.53086426 |
| 136 | amino sugar catabolic process (GO:0046348) | 2.52803819 |
| 137 | fibroblast migration (GO:0010761) | 2.52538439 |
| 138 | transcytosis (GO:0045056) | 2.52029600 |
| 139 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.51707951 |
| 140 | granulocyte activation (GO:0036230) | 2.51225125 |
| 141 | detection of bacterium (GO:0016045) | 2.51188835 |
| 142 | respiratory tube development (GO:0030323) | 2.51137444 |
| 143 | phagocytosis, recognition (GO:0006910) | 2.50846219 |
| 144 | embryonic foregut morphogenesis (GO:0048617) | 2.50606541 |
| 145 | regulation of leukocyte degranulation (GO:0043300) | 2.50011083 |
| 146 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.48620003 |
| 147 | regulation of macrophage cytokine production (GO:0010935) | 2.48501288 |
| 148 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.48287156 |
| 149 | regulation of chemokine biosynthetic process (GO:0045073) | 2.47641334 |
| 150 | membrane raft organization (GO:0031579) | 2.47426524 |
| 151 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.47383661 |
| 152 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.47223214 |
| 153 | regulation of cholesterol storage (GO:0010885) | 2.47178687 |
| 154 | positive regulation of interleukin-6 production (GO:0032755) | 2.46538512 |
| 155 | tissue remodeling (GO:0048771) | 2.46097887 |
| 156 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.46085709 |
| 157 | extracellular matrix disassembly (GO:0022617) | 2.45752771 |
| 158 | negative regulation of lipid storage (GO:0010888) | 2.43288740 |
| 159 | detection of biotic stimulus (GO:0009595) | 2.42243594 |
| 160 | positive regulation of receptor recycling (GO:0001921) | 2.41417028 |
| 161 | adenosine receptor signaling pathway (GO:0001973) | 2.39803628 |
| 162 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.39656850 |
| 163 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.38887994 |
| 164 | regulation of vitamin metabolic process (GO:0030656) | 2.38309237 |
| 165 | regulation of interleukin-6 production (GO:0032675) | 2.38144248 |
| 166 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.37446740 |
| 167 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.36995431 |
| 168 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.36287147 |
| 169 | ceramide catabolic process (GO:0046514) | 2.35673296 |
| 170 | positive regulation of extracellular matrix organization (GO:1903055) | 2.34585676 |
| 171 | positive regulation of heat generation (GO:0031652) | 2.33837946 |
| 172 | regulation of monocyte chemotaxis (GO:0090025) | 2.31646234 |
| 173 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.28493802 |
| 174 | immunoglobulin mediated immune response (GO:0016064) | 2.28013009 |
| 175 | cellular response to lipopolysaccharide (GO:0071222) | 2.27548630 |
| 176 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.27157417 |
| 177 | negative regulation of cell killing (GO:0031342) | 2.27157417 |
| 178 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.26270369 |
| 179 | positive regulation of type 2 immune response (GO:0002830) | 2.26262609 |
| 180 | regulation of fever generation (GO:0031620) | 2.25210666 |
| 181 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.24391783 |
| 182 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.24205252 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.93075371 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.84465667 |
| 3 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.75478408 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.62009284 |
| 5 | * CLOCK_20551151_ChIP-Seq_293T_Human | 3.49381836 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.45811262 |
| 7 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.86376879 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.76177425 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.75960856 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.59741132 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.55434393 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.54548396 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46180205 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.42183771 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.41057732 |
| 16 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.39251302 |
| 17 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.38433634 |
| 18 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.34414305 |
| 19 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.32362277 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.21808680 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.14975616 |
| 22 | CJUN_26792858_Chip-Seq_BT549_Human | 2.06340291 |
| 23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.00476913 |
| 24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.96163825 |
| 25 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.94675429 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.92411076 |
| 27 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.87923007 |
| 28 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.86662543 |
| 29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.85066529 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.84958821 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.84178812 |
| 32 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.82299563 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.78886772 |
| 34 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.78790134 |
| 35 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.78582669 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.78554435 |
| 37 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.76277603 |
| 38 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.73607052 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.72792191 |
| 40 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.68077502 |
| 41 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.68077502 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.66166239 |
| 43 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.59236790 |
| 44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.51595045 |
| 45 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.50904046 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.50834348 |
| 47 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.50388989 |
| 48 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48818501 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.48525549 |
| 50 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.47408760 |
| 51 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.46312930 |
| 52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45900698 |
| 53 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.45444683 |
| 54 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.42963840 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42457719 |
| 56 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.42369418 |
| 57 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.42074066 |
| 58 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.42074066 |
| 59 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.41378906 |
| 60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39751817 |
| 61 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.36496357 |
| 62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.36496357 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35821278 |
| 64 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.35068143 |
| 65 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.34948911 |
| 66 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34900952 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33461356 |
| 68 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.33305174 |
| 69 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.32547650 |
| 70 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.32024250 |
| 71 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31624634 |
| 72 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31366691 |
| 73 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.28766904 |
| 74 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28084954 |
| 75 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24230275 |
| 76 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.23491716 |
| 77 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.23164852 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23056323 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19963756 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19396460 |
| 81 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.19348537 |
| 82 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18353634 |
| 83 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17221886 |
| 84 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.16518741 |
| 85 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.14490605 |
| 86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14286363 |
| 87 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12479118 |
| 88 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12349760 |
| 89 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.08949409 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08746218 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08270717 |
| 92 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07572793 |
| 93 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.07232270 |
| 94 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07147879 |
| 95 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06449742 |
| 96 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05096223 |
| 97 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.05058050 |
| 98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.04756922 |
| 99 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04711171 |
| 100 | KDM2B_26808549_Chip-Seq_K562_Human | 1.04518744 |
| 101 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.04405345 |
| 102 | * MAF_26560356_Chip-Seq_TH1_Human | 1.04140030 |
| 103 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.04074368 |
| 104 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03403892 |
| 105 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.02850871 |
| 106 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.02841738 |
| 107 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.02596290 |
| 108 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.02315547 |
| 109 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.02315547 |
| 110 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01801389 |
| 111 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.01715452 |
| 112 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01540480 |
| 113 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.01508544 |
| 114 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.01383999 |
| 115 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.00429231 |
| 116 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99325199 |
| 117 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.99267552 |
| 118 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98908660 |
| 119 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.98810464 |
| 120 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98174970 |
| 121 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97356240 |
| 122 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96610547 |
| 123 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95409551 |
| 124 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94490073 |
| 125 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94119197 |
| 126 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94083778 |
| 127 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.93296426 |
| 128 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93289014 |
| 129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92898820 |
| 130 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.92445993 |
| 131 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91039169 |
| 132 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90695031 |
| 133 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.89767630 |
| 134 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.89331367 |
| 135 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.88156936 |
| 136 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87741434 |
| 137 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87292434 |
| 138 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87255778 |
| 139 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.87210946 |
| 140 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.86679006 |
| 141 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.86469238 |
| 142 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84942078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 5.39052345 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 5.17917473 |
| 3 | MP0001879_abnormal_lymphatic_vessel | 4.33996084 |
| 4 | MP0004272_abnormal_basement_membrane | 3.98740790 |
| 5 | MP0006054_spinal_hemorrhage | 3.67736250 |
| 6 | MP0005275_abnormal_skin_tensile | 3.57740496 |
| 7 | MP0001958_emphysema | 3.47186358 |
| 8 | MP0005058_abnormal_lysosome_morphology | 3.32338642 |
| 9 | MP0003724_increased_susceptibility_to | 3.11575708 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 3.10769393 |
| 11 | MP0009840_abnormal_foam_cell | 2.98952918 |
| 12 | MP0003436_decreased_susceptibility_to | 2.94197015 |
| 13 | MP0003279_aneurysm | 2.71976806 |
| 14 | MP0005167_abnormal_blood-brain_barrier | 2.62142476 |
| 15 | MP0000013_abnormal_adipose_tissue | 2.53305668 |
| 16 | MP0005451_abnormal_body_composition | 2.41540308 |
| 17 | MP0005503_abnormal_tendon_morphology | 2.38932771 |
| 18 | MP0006082_CNS_inflammation | 2.29590844 |
| 19 | MP0003566_abnormal_cell_adhesion | 2.25557847 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.22738065 |
| 21 | MP0003828_pulmonary_edema | 2.20176018 |
| 22 | MP0002419_abnormal_innate_immunity | 2.19123166 |
| 23 | MP0003075_altered_response_to | 2.16910079 |
| 24 | MP0003453_abnormal_keratinocyte_physiol | 2.10798577 |
| 25 | MP0009785_altered_susceptibility_to | 2.02396268 |
| 26 | MP0000767_abnormal_smooth_muscle | 2.00607576 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.98196695 |
| 28 | MP0004947_skin_inflammation | 1.95019473 |
| 29 | MP0005623_abnormal_meninges_morphology | 1.90994977 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.89611361 |
| 31 | MP0002295_abnormal_pulmonary_circulatio | 1.87060863 |
| 32 | MP0004084_abnormal_cardiac_muscle | 1.86871975 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.73323837 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.72419524 |
| 35 | MP0005025_abnormal_response_to | 1.68023915 |
| 36 | MP0004782_abnormal_surfactant_physiolog | 1.65509698 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.62850297 |
| 38 | MP0003091_abnormal_cell_migration | 1.62756545 |
| 39 | MP0009764_decreased_sensitivity_to | 1.60859803 |
| 40 | MP0006138_congestive_heart_failure | 1.59484532 |
| 41 | MP0000604_amyloidosis | 1.59165943 |
| 42 | MP0001790_abnormal_immune_system | 1.56797272 |
| 43 | MP0005387_immune_system_phenotype | 1.56797272 |
| 44 | MP0008004_abnormal_stomach_pH | 1.56121816 |
| 45 | MP0002796_impaired_skin_barrier | 1.52289055 |
| 46 | MP0000858_altered_metastatic_potential | 1.49312135 |
| 47 | * MP0000343_altered_response_to | 1.48760725 |
| 48 | MP0001835_abnormal_antigen_presentation | 1.47949696 |
| 49 | MP0002452_abnormal_antigen_presenting | 1.40562336 |
| 50 | MP0005670_abnormal_white_adipose | 1.40392346 |
| 51 | MP0005023_abnormal_wound_healing | 1.40337223 |
| 52 | MP0003045_fibrosis | 1.40207401 |
| 53 | MP0003950_abnormal_plasma_membrane | 1.39442082 |
| 54 | MP0005595_abnormal_vascular_smooth | 1.38995615 |
| 55 | MP0001853_heart_inflammation | 1.37326951 |
| 56 | MP0004130_abnormal_muscle_cell | 1.35881922 |
| 57 | MP0005166_decreased_susceptibility_to | 1.31866438 |
| 58 | MP0002405_respiratory_system_inflammati | 1.31709749 |
| 59 | MP0000249_abnormal_blood_vessel | 1.28610779 |
| 60 | MP0002133_abnormal_respiratory_system | 1.26843797 |
| 61 | MP0005388_respiratory_system_phenotype | 1.26843797 |
| 62 | * MP0002723_abnormal_immune_serum | 1.26371352 |
| 63 | MP0009780_abnormal_chondrocyte_physiolo | 1.26218173 |
| 64 | MP0009384_cardiac_valve_regurgitation | 1.26045205 |
| 65 | MP0000685_abnormal_immune_system | 1.25271240 |
| 66 | MP0002128_abnormal_blood_circulation | 1.24115740 |
| 67 | MP0000003_abnormal_adipose_tissue | 1.21943485 |
| 68 | MP0003690_abnormal_glial_cell | 1.21933292 |
| 69 | MP0000751_myopathy | 1.19774493 |
| 70 | MP0004883_abnormal_blood_vessel | 1.18644041 |
| 71 | MP0005385_cardiovascular_system_phenoty | 1.18501084 |
| 72 | MP0001544_abnormal_cardiovascular_syste | 1.18501084 |
| 73 | * MP0001845_abnormal_inflammatory_respons | 1.17549885 |
| 74 | MP0005508_abnormal_skeleton_morphology | 1.17467818 |
| 75 | MP0004036_abnormal_muscle_relaxation | 1.14830788 |
| 76 | * MP0005164_abnormal_response_to | 1.13986400 |
| 77 | MP0001545_abnormal_hematopoietic_system | 1.13030101 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 1.13030101 |
| 79 | MP0002837_dystrophic_cardiac_calcinosis | 1.12507919 |
| 80 | MP0005464_abnormal_platelet_physiology | 1.11766086 |
| 81 | MP0002060_abnormal_skin_morphology | 1.11070895 |
| 82 | MP0001614_abnormal_blood_vessel | 1.10225077 |
| 83 | MP0005671_abnormal_response_to | 1.09696372 |
| 84 | * MP0002420_abnormal_adaptive_immunity | 1.09401269 |
| 85 | MP0010234_abnormal_vibrissa_follicle | 1.08927142 |
| 86 | MP0005165_increased_susceptibility_to | 1.08571562 |
| 87 | * MP0001819_abnormal_immune_cell | 1.08227467 |
| 88 | MP0001533_abnormal_skeleton_physiology | 1.07882016 |
| 89 | MP0008775_abnormal_heart_ventricle | 1.07755205 |
| 90 | MP0001800_abnormal_humoral_immune | 1.07268420 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 1.07207174 |
| 92 | * MP0002925_abnormal_cardiovascular_devel | 1.06302525 |
| 93 | MP0010155_abnormal_intestine_physiology | 1.06259551 |
| 94 | MP0001542_abnormal_bone_strength | 1.05435167 |
| 95 | * MP0008469_abnormal_protein_level | 1.04738638 |
| 96 | MP0010352_gastrointestinal_tract_polyps | 1.03614533 |
| 97 | MP0005375_adipose_tissue_phenotype | 1.02913332 |
| 98 | MP0003303_peritoneal_inflammation | 1.01781854 |
| 99 | MP0002139_abnormal_hepatobiliary_system | 1.00496525 |
| 100 | MP0002168_other_aberrant_phenotype | 0.99726892 |
| 101 | MP0004185_abnormal_adipocyte_glucose | 0.99093325 |
| 102 | MP0002254_reproductive_system_inflammat | 0.98970833 |
| 103 | MP0000750_abnormal_muscle_regeneration | 0.97939655 |
| 104 | MP0003656_abnormal_erythrocyte_physiolo | 0.97427216 |
| 105 | MP0008260_abnormal_autophagy | 0.96543299 |
| 106 | MP0003329_amyloid_beta_deposits | 0.96031919 |
| 107 | MP0001851_eye_inflammation | 0.94686278 |
| 108 | MP0010630_abnormal_cardiac_muscle | 0.94673649 |
| 109 | MP0004215_abnormal_myocardial_fiber | 0.93049812 |
| 110 | MP0004233_abnormal_muscle_weight | 0.91223986 |
| 111 | MP0001216_abnormal_epidermal_layer | 0.89976951 |
| 112 | MP0004484_altered_response_of | 0.89218481 |
| 113 | MP0009278_abnormal_bone_marrow | 0.88270005 |
| 114 | MP0002896_abnormal_bone_mineralization | 0.88122805 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.88007517 |
| 116 | MP0005390_skeleton_phenotype | 0.87511867 |
| 117 | MP0002972_abnormal_cardiac_muscle | 0.87152081 |
| 118 | MP0002998_abnormal_bone_remodeling | 0.86284438 |
| 119 | MP0003448_altered_tumor_morphology | 0.85768856 |
| 120 | MP0001915_intracranial_hemorrhage | 0.85480730 |
| 121 | MP0002933_joint_inflammation | 0.83190607 |
| 122 | MP0002332_abnormal_exercise_endurance | 0.83131002 |
| 123 | MP0004087_abnormal_muscle_fiber | 0.82041839 |
| 124 | * MP0001175_abnormal_lung_morphology | 0.81903242 |
| 125 | MP0000733_abnormal_muscle_development | 0.79859768 |
| 126 | MP0003795_abnormal_bone_structure | 0.77506644 |
| 127 | MP0000747_muscle_weakness | 0.76711311 |
| 128 | MP0009333_abnormal_splenocyte_physiolog | 0.76490163 |
| 129 | MP0005409_darkened_coat_color | 0.76459150 |
| 130 | MP0005620_abnormal_muscle_contractility | 0.76388946 |
| 131 | MP0000534_abnormal_ureter_morphology | 0.75786103 |
| 132 | MP0003385_abnormal_body_wall | 0.75084570 |
| 133 | MP0001849_ear_inflammation | 0.74694798 |
| 134 | MP0002108_abnormal_muscle_morphology | 0.74679216 |
| 135 | * MP0000266_abnormal_heart_morphology | 0.74609321 |
| 136 | MP0003115_abnormal_respiratory_system | 0.73042606 |
| 137 | MP0005330_cardiomyopathy | 0.71053332 |
| 138 | MP0002282_abnormal_trachea_morphology | 0.69617063 |
| 139 | MP0004510_myositis | 0.68877876 |
| 140 | MP0001177_atelectasis | 0.67758139 |
| 141 | MP0000537_abnormal_urethra_morphology | 0.66755861 |
| 142 | MP0001243_abnormal_dermal_layer | 0.65438142 |
| 143 | MP0000230_abnormal_systemic_arterial | 0.65407144 |
| 144 | MP0001784_abnormal_fluid_regulation | 0.63921792 |
| 145 | MP0005076_abnormal_cell_differentiation | 0.62984696 |
| 146 | MP0000516_abnormal_urinary_system | 0.61877015 |
| 147 | MP0005367_renal/urinary_system_phenotyp | 0.61877015 |
| 148 | MP0002166_altered_tumor_susceptibility | 0.59571171 |
| 149 | MP0002877_abnormal_melanocyte_morpholog | 0.57694899 |
| 150 | MP0003567_abnormal_fetal_cardiomyocyte | 0.56351194 |
| 151 | MP0004085_abnormal_heartbeat | 0.56198738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 5.65326815 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.65326815 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.65326815 |
| 4 | Hematochezia (HP:0002573) | 5.23299900 |
| 5 | Protrusio acetabuli (HP:0003179) | 5.20186751 |
| 6 | Premature rupture of membranes (HP:0001788) | 5.13350878 |
| 7 | Broad metatarsal (HP:0001783) | 4.91740985 |
| 8 | Cerebral aneurysm (HP:0004944) | 4.89815432 |
| 9 | Polycythemia (HP:0001901) | 4.67383804 |
| 10 | Spontaneous hematomas (HP:0007420) | 4.27792546 |
| 11 | Aortic dissection (HP:0002647) | 4.14830842 |
| 12 | Aortic aneurysm (HP:0004942) | 4.13010881 |
| 13 | Increased cerebral lipofuscin (HP:0011813) | 4.10299201 |
| 14 | Nonimmune hydrops fetalis (HP:0001790) | 3.86663607 |
| 15 | Ankle contracture (HP:0006466) | 3.78296347 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 3.73000623 |
| 17 | Dysostosis multiplex (HP:0000943) | 3.72082048 |
| 18 | Abnormality of macrophages (HP:0004311) | 3.70472862 |
| 19 | Vacuolated lymphocytes (HP:0001922) | 3.69601333 |
| 20 | Shallow orbits (HP:0000586) | 3.63614169 |
| 21 | Eczematoid dermatitis (HP:0000976) | 3.55801901 |
| 22 | Loss of speech (HP:0002371) | 3.44232929 |
| 23 | Distal lower limb amyotrophy (HP:0008944) | 3.41875154 |
| 24 | Axonal loss (HP:0003447) | 3.40737676 |
| 25 | Increased connective tissue (HP:0009025) | 3.30397821 |
| 26 | Interstitial pulmonary disease (HP:0006530) | 3.26459656 |
| 27 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.24753097 |
| 28 | Atrophic scars (HP:0001075) | 3.24689505 |
| 29 | Abnormality of the nasal mucosa (HP:0000433) | 3.24481337 |
| 30 | Neurofibrillary tangles (HP:0002185) | 3.08171553 |
| 31 | Distal lower limb muscle weakness (HP:0009053) | 3.08006018 |
| 32 | Vascular tortuosity (HP:0004948) | 3.06661145 |
| 33 | Spinal rigidity (HP:0003306) | 2.97433545 |
| 34 | Recurrent abscess formation (HP:0002722) | 2.96812357 |
| 35 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.95733408 |
| 36 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.95733408 |
| 37 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.95733408 |
| 38 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.94247149 |
| 39 | Aneurysm (HP:0002617) | 2.93851212 |
| 40 | Bladder diverticulum (HP:0000015) | 2.92274143 |
| 41 | Recurrent bacterial skin infections (HP:0005406) | 2.91454042 |
| 42 | Disinhibition (HP:0000734) | 2.90380256 |
| 43 | Asymmetric septal hypertrophy (HP:0001670) | 2.89866786 |
| 44 | Mitral valve prolapse (HP:0001634) | 2.88303633 |
| 45 | Muscle fiber inclusion bodies (HP:0100299) | 2.87107591 |
| 46 | Glomerulonephritis (HP:0000099) | 2.86865032 |
| 47 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.85007076 |
| 48 | Mucopolysacchariduria (HP:0008155) | 2.85007076 |
| 49 | Cervical subluxation (HP:0003308) | 2.84225459 |
| 50 | Pulmonary artery stenosis (HP:0004415) | 2.83619589 |
| 51 | Amyloidosis (HP:0011034) | 2.80365658 |
| 52 | Esophageal varix (HP:0002040) | 2.78985787 |
| 53 | Arterial tortuosity (HP:0005116) | 2.78223310 |
| 54 | Nuclear cataract (HP:0100018) | 2.77882728 |
| 55 | Myositis (HP:0100614) | 2.77396234 |
| 56 | Peritonitis (HP:0002586) | 2.77121522 |
| 57 | Orchitis (HP:0100796) | 2.75442588 |
| 58 | Osteolytic defects of the hand bones (HP:0009699) | 2.72809899 |
| 59 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.72809899 |
| 60 | Increased variability in muscle fiber diameter (HP:0003557) | 2.72577396 |
| 61 | Soft skin (HP:0000977) | 2.70709400 |
| 62 | Right ventricular cardiomyopathy (HP:0011663) | 2.69353021 |
| 63 | Dilatation of the ascending aorta (HP:0005111) | 2.67584630 |
| 64 | Camptodactyly of toe (HP:0001836) | 2.67381517 |
| 65 | Type 1 muscle fiber predominance (HP:0003803) | 2.67028799 |
| 66 | Short hallux (HP:0010109) | 2.65841225 |
| 67 | Thick nail (HP:0001805) | 2.65750085 |
| 68 | Myocardial infarction (HP:0001658) | 2.61838485 |
| 69 | Difficulty climbing stairs (HP:0003551) | 2.61805538 |
| 70 | Conjunctival telangiectasia (HP:0000524) | 2.60995675 |
| 71 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.60025970 |
| 72 | Increased IgE level (HP:0003212) | 2.59161921 |
| 73 | Fragile skin (HP:0001030) | 2.57928143 |
| 74 | Lymphangioma (HP:0100764) | 2.56993180 |
| 75 | Muscle fiber splitting (HP:0003555) | 2.55938511 |
| 76 | Visceral angiomatosis (HP:0100761) | 2.53498815 |
| 77 | Wrist flexion contracture (HP:0001239) | 2.52592244 |
| 78 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.51703060 |
| 79 | Follicular hyperkeratosis (HP:0007502) | 2.50079906 |
| 80 | Cerebral hemorrhage (HP:0001342) | 2.47207240 |
| 81 | Cerebral inclusion bodies (HP:0100314) | 2.45603075 |
| 82 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.44594405 |
| 83 | Venous abnormality (HP:0002624) | 2.41580385 |
| 84 | Hyporeflexia of lower limbs (HP:0002600) | 2.37813410 |
| 85 | Lower limb amyotrophy (HP:0007210) | 2.35620733 |
| 86 | Hemangiomatosis (HP:0007461) | 2.34277624 |
| 87 | Long toe (HP:0010511) | 2.33799906 |
| 88 | Wormian bones (HP:0002645) | 2.32510113 |
| 89 | Complement deficiency (HP:0004431) | 2.30423641 |
| 90 | Venous insufficiency (HP:0005293) | 2.30194150 |
| 91 | Tetraparesis (HP:0002273) | 2.29855660 |
| 92 | Autoimmune thrombocytopenia (HP:0001973) | 2.28589519 |
| 93 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.27750769 |
| 94 | Disproportionate tall stature (HP:0001519) | 2.26047073 |
| 95 | Mutism (HP:0002300) | 2.25927563 |
| 96 | Abnormality of complement system (HP:0005339) | 2.25222744 |
| 97 | Retrobulbar optic neuritis (HP:0100654) | 2.25017384 |
| 98 | Optic neuritis (HP:0100653) | 2.25017384 |
| 99 | Blue sclerae (HP:0000592) | 2.24504145 |
| 100 | Stomatitis (HP:0010280) | 2.23918002 |
| 101 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.19605598 |
| 102 | Ventricular tachycardia (HP:0004756) | 2.18871591 |
| 103 | Ulnar bowing (HP:0003031) | 2.17525350 |
| 104 | Acanthosis nigricans (HP:0000956) | 2.17455269 |
| 105 | Hyperactive renin-angiotensin system (HP:0000841) | 2.14638813 |
| 106 | Growth hormone excess (HP:0000845) | 2.13896805 |
| 107 | Pulmonary hypertension (HP:0002092) | 2.11536019 |
| 108 | Mediastinal lymphadenopathy (HP:0100721) | 2.10954405 |
| 109 | Nemaline bodies (HP:0003798) | 2.10098266 |
| 110 | Gingivitis (HP:0000230) | 2.09905486 |
| 111 | Apathy (HP:0000741) | 2.08085810 |
| 112 | Keratoconjunctivitis sicca (HP:0001097) | 2.08019894 |
| 113 | Upper motor neuron abnormality (HP:0002127) | 2.07316211 |
| 114 | Flexion contracture of toe (HP:0005830) | 2.06349558 |
| 115 | Joint contractures involving the joints of the feet (HP:0100492) | 2.06349558 |
| 116 | Striae distensae (HP:0001065) | 2.05759122 |
| 117 | Mucosal telangiectasiae (HP:0100579) | 2.04017166 |
| 118 | Diminished motivation (HP:0000745) | 2.03465272 |
| 119 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.01661890 |
| 120 | Neuronal loss in central nervous system (HP:0002529) | 2.01137113 |
| 121 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.98804919 |
| 122 | Hyperextensible skin (HP:0000974) | 1.98195286 |
| 123 | Vertebral compression fractures (HP:0002953) | 1.97245870 |
| 124 | Joint laxity (HP:0001388) | 1.96183638 |
| 125 | Increased serum ferritin (HP:0003281) | 1.94354293 |
| 126 | Round ear (HP:0100830) | 1.92627664 |
| 127 | Rectal prolapse (HP:0002035) | 1.92495517 |
| 128 | Slender build (HP:0001533) | 1.91955755 |
| 129 | Bowed forearm bones (HP:0003956) | 1.91917410 |
| 130 | Bowing of the arm (HP:0006488) | 1.91917410 |
| 131 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.91266776 |
| 132 | Difficulty running (HP:0009046) | 1.90972159 |
| 133 | Purpura (HP:0000979) | 1.90121342 |
| 134 | Bronchomalacia (HP:0002780) | 1.89090028 |
| 135 | Chondrocalcinosis (HP:0000934) | 1.88756469 |
| 136 | Mitral regurgitation (HP:0001653) | 1.86226429 |
| 137 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.85657619 |
| 138 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.85657619 |
| 139 | Single umbilical artery (HP:0001195) | 1.85657619 |
| 140 | Nephritis (HP:0000123) | 1.84468225 |
| 141 | Pathologic fracture (HP:0002756) | 1.83912009 |
| 142 | Abnormality of dentin (HP:0010299) | 1.83378923 |
| 143 | Bicuspid aortic valve (HP:0001647) | 1.83226329 |
| 144 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.83162788 |
| 145 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.82818376 |
| 146 | Keratoconjunctivitis (HP:0001096) | 1.81266543 |
| 147 | Ectopia lentis (HP:0001083) | 1.80489579 |
| 148 | Lipoatrophy (HP:0100578) | 1.79501712 |
| 149 | Abnormality of the peritoneum (HP:0002585) | 1.79066537 |
| 150 | Progressive neurologic deterioration (HP:0002344) | 1.78941386 |
| 151 | Hydroureter (HP:0000072) | 1.78394144 |
| 152 | Hypoplasia of the iris (HP:0007676) | 1.78193072 |
| 153 | Bone pain (HP:0002653) | 1.77332592 |
| 154 | Increased CSF protein (HP:0002922) | 1.77290109 |
| 155 | Buphthalmos (HP:0000557) | 1.76350489 |
| 156 | Short nail (HP:0001799) | 1.76036603 |
| 157 | Bulbar palsy (HP:0001283) | 1.75519697 |
| 158 | Aortic valve stenosis (HP:0001650) | 1.74886585 |
| 159 | Hypoplastic ischia (HP:0003175) | 1.74449114 |
| 160 | Abnormality of Sharpey fibers (HP:0100685) | 1.73952789 |
| 161 | Genu recurvatum (HP:0002816) | 1.73857467 |
| 162 | Spondylolisthesis (HP:0003302) | 1.73458779 |
| 163 | Bowel diverticulosis (HP:0005222) | 1.72133086 |
| 164 | Supranuclear gaze palsy (HP:0000605) | 1.71318829 |
| 165 | Osteopenia (HP:0000938) | 1.70285845 |
| 166 | Hepatosplenomegaly (HP:0001433) | 1.70200384 |
| 167 | Joint stiffness (HP:0001387) | 1.69832547 |
| 168 | Facial shape deformation (HP:0011334) | 1.69823878 |
| 169 | Potter facies (HP:0002009) | 1.69823878 |
| 170 | Cavernous hemangioma (HP:0001048) | 1.68784991 |
| 171 | Exercise-induced myalgia (HP:0003738) | 1.68662833 |
| 172 | EMG: myopathic abnormalities (HP:0003458) | 1.68441474 |
| 173 | Malnutrition (HP:0004395) | 1.68376932 |
| 174 | Gangrene (HP:0100758) | 1.68070341 |
| 175 | Abnormality of nail color (HP:0100643) | 1.67345023 |
| 176 | Alopecia of scalp (HP:0002293) | 1.65315346 |
| 177 | Hemoptysis (HP:0002105) | 1.63663460 |
| 178 | Urticaria (HP:0001025) | 1.60035948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 7.53601668 |
| 2 | KDR | 5.82871789 |
| 3 | IRAK3 | 4.53518506 |
| 4 | TGFBR2 | 4.26889936 |
| 5 | ERN1 | 2.84929683 |
| 6 | RIPK1 | 2.74778341 |
| 7 | EPHB2 | 2.73460555 |
| 8 | TRIB3 | 2.69590557 |
| 9 | TTN | 2.57122230 |
| 10 | BLK | 2.42103950 |
| 11 | PDGFRA | 2.16889271 |
| 12 | MAP3K14 | 2.13994692 |
| 13 | TGFBR1 | 2.09824787 |
| 14 | PRPF4B | 2.07201369 |
| 15 | TAOK2 | 2.03824025 |
| 16 | MYLK | 2.03073342 |
| 17 | EPHB1 | 1.99874815 |
| 18 | DMPK | 1.99301500 |
| 19 | GRK7 | 1.86386914 |
| 20 | NME2 | 1.86222625 |
| 21 | DDR2 | 1.82764928 |
| 22 | FER | 1.81412112 |
| 23 | TAOK1 | 1.72403680 |
| 24 | PTK2B | 1.66022326 |
| 25 | PAK4 | 1.62116465 |
| 26 | MAP3K11 | 1.59045260 |
| 27 | IRAK4 | 1.54828876 |
| 28 | MAP3K13 | 1.54755990 |
| 29 | LRRK2 | 1.41923542 |
| 30 | PTK6 | 1.41231197 |
| 31 | CDC42BPA | 1.39865380 |
| 32 | PKN2 | 1.38940187 |
| 33 | LATS1 | 1.37753543 |
| 34 | FGFR4 | 1.33785923 |
| 35 | EPHA3 | 1.30530922 |
| 36 | RIPK4 | 1.30237562 |
| 37 | FGR | 1.25002522 |
| 38 | MATK | 1.22080465 |
| 39 | SIK1 | 1.21990436 |
| 40 | JAK1 | 1.18699090 |
| 41 | PTK2 | 1.17788955 |
| 42 | IKBKB | 1.14088920 |
| 43 | ABL2 | 1.13450583 |
| 44 | CAMK1D | 1.08474363 |
| 45 | LATS2 | 1.07903937 |
| 46 | MAP2K3 | 1.06289971 |
| 47 | FGFR2 | 1.03020073 |
| 48 | FGFR3 | 1.02262025 |
| 49 | IRAK1 | 1.00528350 |
| 50 | TESK1 | 0.98676048 |
| 51 | MAP3K6 | 0.98389443 |
| 52 | MAP3K3 | 0.97378528 |
| 53 | MAPK7 | 0.97149672 |
| 54 | LMTK2 | 0.95838659 |
| 55 | STK10 | 0.95735771 |
| 56 | IRAK2 | 0.94734867 |
| 57 | CSK | 0.94214802 |
| 58 | PDGFRB | 0.93503229 |
| 59 | OBSCN | 0.93420460 |
| 60 | MAP4K1 | 0.93255182 |
| 61 | PRKD1 | 0.93116578 |
| 62 | PAK2 | 0.90623155 |
| 63 | TRPM7 | 0.90078776 |
| 64 | GRK1 | 0.89414616 |
| 65 | NEK9 | 0.86027550 |
| 66 | MARK2 | 0.84160902 |
| 67 | IKBKE | 0.83569032 |
| 68 | CAMK1G | 0.76753540 |
| 69 | MET | 0.75594677 |
| 70 | MST4 | 0.75480442 |
| 71 | ICK | 0.75271703 |
| 72 | PRKCH | 0.75028409 |
| 73 | FES | 0.70633484 |
| 74 | PRKG2 | 0.69474164 |
| 75 | SIK3 | 0.69443518 |
| 76 | MAP2K1 | 0.69417986 |
| 77 | JAK3 | 0.68384060 |
| 78 | ARAF | 0.67558284 |
| 79 | BMPR2 | 0.65923667 |
| 80 | TYK2 | 0.63749482 |
| 81 | RPS6KL1 | 0.62341732 |
| 82 | ROCK1 | 0.61252233 |
| 83 | STK3 | 0.60125925 |
| 84 | FRK | 0.59014719 |
| 85 | RPS6KA2 | 0.58802308 |
| 86 | CSF1R | 0.58572972 |
| 87 | CHUK | 0.58528316 |
| 88 | MAPK4 | 0.58173023 |
| 89 | ILK | 0.58104038 |
| 90 | RET | 0.57755884 |
| 91 | PDK2 | 0.57624404 |
| 92 | EPHA2 | 0.57405505 |
| 93 | BMX | 0.55264260 |
| 94 | PAK3 | 0.54549719 |
| 95 | MAP3K5 | 0.54298302 |
| 96 | MAPKAPK3 | 0.54030823 |
| 97 | JAK2 | 0.52628470 |
| 98 | GSK3A | 0.52062504 |
| 99 | SRC | 0.47327242 |
| 100 | RPS6KA6 | 0.46413998 |
| 101 | MAPK12 | 0.46390801 |
| 102 | LIMK1 | 0.45942538 |
| 103 | MAP2K6 | 0.45884550 |
| 104 | PIK3CA | 0.45748830 |
| 105 | MAP3K7 | 0.44578544 |
| 106 | PRKD2 | 0.44154039 |
| 107 | DAPK2 | 0.43730762 |
| 108 | TEC | 0.42762497 |
| 109 | IGF1R | 0.42661693 |
| 110 | LYN | 0.42362424 |
| 111 | PIK3CG | 0.42189817 |
| 112 | MAPKAPK2 | 0.41945142 |
| 113 | FGFR1 | 0.41845829 |
| 114 | KSR2 | 0.41444670 |
| 115 | ROCK2 | 0.41265115 |
| 116 | SYK | 0.40504965 |
| 117 | NTRK1 | 0.40466072 |
| 118 | CAMK4 | 0.40450968 |
| 119 | EGFR | 0.40421434 |
| 120 | CDK6 | 0.39359464 |
| 121 | PDPK1 | 0.37921665 |
| 122 | ZAP70 | 0.37632097 |
| 123 | INSR | 0.37515649 |
| 124 | SGK3 | 0.37454066 |
| 125 | MTOR | 0.36580759 |
| 126 | MAP3K1 | 0.35614998 |
| 127 | MST1R | 0.35384786 |
| 128 | KIT | 0.35122514 |
| 129 | PRKD3 | 0.34599017 |
| 130 | ABL1 | 0.29364610 |
| 131 | STK24 | 0.28495851 |
| 132 | CDK9 | 0.27897793 |
| 133 | TBK1 | 0.26974994 |
| 134 | PRKCE | 0.26354357 |
| 135 | PIM2 | 0.26283242 |
| 136 | RPS6KA4 | 0.25349721 |
| 137 | DAPK3 | 0.25098437 |
| 138 | PRKAA2 | 0.24885647 |
| 139 | PHKG2 | 0.24866642 |
| 140 | PHKG1 | 0.24866642 |
| 141 | MARK3 | 0.23928848 |
| 142 | MAP3K2 | 0.22690004 |
| 143 | MAP2K2 | 0.22612930 |
| 144 | HCK | 0.21024757 |
| 145 | MAP3K10 | 0.20634253 |
| 146 | MOS | 0.20605827 |
| 147 | RPS6KC1 | 0.19632444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.54570565 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.15394374 |
| 3 | Focal adhesion_Homo sapiens_hsa04510 | 2.83505784 |
| 4 | Malaria_Homo sapiens_hsa05144 | 2.33159747 |
| 5 | Adherens junction_Homo sapiens_hsa04520 | 2.14083814 |
| 6 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.09878889 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.05987519 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.01877065 |
| 9 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.00107774 |
| 10 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.96334095 |
| 11 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.95880023 |
| 12 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.90629319 |
| 13 | Amoebiasis_Homo sapiens_hsa05146 | 1.87126704 |
| 14 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.85019888 |
| 15 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.79172946 |
| 16 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.75515171 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.73662496 |
| 18 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.67781640 |
| 19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.67684709 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.63576391 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.58924936 |
| 22 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.53628968 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.51455706 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.46481933 |
| 25 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.44358652 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.42515805 |
| 27 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.40216220 |
| 28 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.38137101 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36665212 |
| 30 | Platelet activation_Homo sapiens_hsa04611 | 1.36379718 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.30736412 |
| 32 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.27522994 |
| 33 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.19994320 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.19720957 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.18888001 |
| 36 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.16607505 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.15842286 |
| 38 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.15737742 |
| 39 | Tight junction_Homo sapiens_hsa04530 | 1.12766621 |
| 40 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07408943 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.07077937 |
| 42 | Asthma_Homo sapiens_hsa05310 | 1.06571271 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.05832230 |
| 44 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.03685908 |
| 45 | Pathways in cancer_Homo sapiens_hsa05200 | 1.03622962 |
| 46 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.03452077 |
| 47 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.02225980 |
| 48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.02042195 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01896634 |
| 50 | Bladder cancer_Homo sapiens_hsa05219 | 1.01634284 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01528309 |
| 52 | Renin secretion_Homo sapiens_hsa04924 | 1.01416397 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01304495 |
| 54 | Axon guidance_Homo sapiens_hsa04360 | 1.00774878 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.97804052 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 0.97725588 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 0.97350172 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96343732 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.96279588 |
| 60 | Lysosome_Homo sapiens_hsa04142 | 0.96151302 |
| 61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.95724640 |
| 62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.95472715 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94456380 |
| 64 | Salmonella infection_Homo sapiens_hsa05132 | 0.91808336 |
| 65 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.91143358 |
| 66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90773051 |
| 67 | Shigellosis_Homo sapiens_hsa05131 | 0.88527514 |
| 68 | Mineral absorption_Homo sapiens_hsa04978 | 0.87704584 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87233932 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.86991453 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86041871 |
| 72 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85388246 |
| 73 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.85197109 |
| 74 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.85148335 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.84858969 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83990703 |
| 77 | Leishmaniasis_Homo sapiens_hsa05140 | 0.82953893 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81254791 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81051620 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.79577744 |
| 81 | Melanoma_Homo sapiens_hsa05218 | 0.79105312 |
| 82 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78868271 |
| 83 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76725466 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76630317 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.76531060 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 0.76125413 |
| 87 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75654294 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75644299 |
| 89 | Measles_Homo sapiens_hsa05162 | 0.73018045 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71320495 |
| 91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.70954515 |
| 92 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.70863636 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.68912357 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68484996 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65615620 |
| 96 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.65496726 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64854471 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62706393 |
| 99 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.62321997 |
| 100 | Melanogenesis_Homo sapiens_hsa04916 | 0.60928988 |
| 101 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.60671838 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59853925 |
| 103 | Gap junction_Homo sapiens_hsa04540 | 0.59167754 |
| 104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59096217 |
| 105 | Tuberculosis_Homo sapiens_hsa05152 | 0.58246413 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.57928409 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57734015 |
| 108 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57601201 |
| 109 | Prostate cancer_Homo sapiens_hsa05215 | 0.57423993 |
| 110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57081016 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56343695 |
| 112 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55707110 |
| 113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54339410 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53008035 |
| 115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52884738 |
| 116 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52748418 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50387523 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49984197 |
| 119 | Apoptosis_Homo sapiens_hsa04210 | 0.49965299 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49636424 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49579122 |
| 122 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.48757485 |
| 123 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47927805 |
| 124 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47920605 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.47597552 |
| 126 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47453922 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46949724 |
| 128 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46238094 |
| 129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45224234 |
| 130 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44873505 |
| 131 | Glioma_Homo sapiens_hsa05214 | 0.44839887 |
| 132 | Hepatitis C_Homo sapiens_hsa05160 | 0.44568141 |
| 133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44491348 |
| 134 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.44119564 |
| 135 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.43922294 |
| 136 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42300074 |
| 137 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41285510 |
| 138 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40197608 |
| 139 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39428697 |

